Published in Kidney Int on January 31, 2007
Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int (2012) 2.97
Transcriptome analysis of human diabetic kidney disease. Diabetes (2011) 2.32
Abnormal angiogenesis in diabetic nephropathy. Diabetes (2009) 1.53
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag (2008) 1.49
Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A (2010) 1.42
Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it? J Cell Commun Signal (2009) 1.33
Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One (2012) 1.31
Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol (2009) 1.27
Genome-wide analysis of Ollier disease: Is it all in the genes? Orphanet J Rare Dis (2011) 1.24
Abnormalities in signaling pathways in diabetic nephropathy. Expert Rev Endocrinol Metab (2010) 1.19
Vegfa protects the glomerular microvasculature in diabetes. Diabetes (2012) 1.16
Molecular mechanisms of diabetic vascular complications. J Diabetes Investig (2010) 1.01
Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes (2009) 0.96
Insulin directly stimulates VEGF-A production in the glomerular podocyte. Am J Physiol Renal Physiol (2013) 0.93
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy. J Am Soc Nephrol (2014) 0.92
MutSβ and histone deacetylase complexes promote expansions of trinucleotide repeats in human cells. Nucleic Acids Res (2012) 0.92
Renal endothelial dysfunction in diabetic nephropathy. Cardiovasc Hematol Disord Drug Targets (2014) 0.90
HIV-associated nephropathy: role of mammalian target of rapamycin pathway. Am J Pathol (2010) 0.89
Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice. J Diabetes Res (2014) 0.88
Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1. J Diabetes Res (2013) 0.87
Podocytes, signaling pathways, and vascular factors in diabetic kidney disease. Adv Chronic Kidney Dis (2014) 0.86
Laser capture microdissection and multiplex-tandem PCR analysis of proximal tubular epithelial cell signaling in human kidney disease. PLoS One (2014) 0.84
Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy. Exp Ther Med (2013) 0.83
Intrinsic carnosine metabolism in the human kidney. Amino Acids (2015) 0.82
Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. J Diabetes Res (2013) 0.81
Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis. Exp Diabetes Res (2012) 0.81
Effect of strawberry (Fragaria × ananassa) leaf extract on diabetic nephropathy in rats. Int J Exp Pathol (2015) 0.80
A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes. PLoS One (2015) 0.80
Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies. PLoS One (2012) 0.80
Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes. J Biol Chem (2014) 0.80
Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia. PLoS One (2016) 0.79
ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy. Sci Rep (2016) 0.79
Quantitating glomerular endothelial fenestration: an unbiased stereological approach. Am J Nephrol (2011) 0.78
A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications. J Diabetes Res (2015) 0.78
The 26S proteasome drives trinucleotide repeat expansions. Nucleic Acids Res (2013) 0.78
Candidate Gene Analysis of Mortality in Dialysis Patients. PLoS One (2015) 0.77
6. Diabetic Nephropathy. EJIFCC (2009) 0.77
Effect of angiogenesis induced by consecutive intramuscular injections of vascular endothelial growth factor in a hindlimb ischemic mouse model. Nucl Med Mol Imaging (2014) 0.77
[Gene expression analyses of kidney biopsies: the European renal cDNA bank--Kröner-Fresenius biopsy bank]. Pathologe (2009) 0.76
Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat. Int J Clin Exp Med (2015) 0.75
Effects of extremely low frequency pulsed magnetic fields on diabetic nephropathy in streptozotocin-treated rats. Biomed Eng Online (2016) 0.75
Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy. Front Endocrinol (Lausanne) (2014) 0.75
Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease. PLoS One (2016) 0.75
Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance. PLoS One (2015) 0.75
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol (1995) 3.06
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer (1990) 2.91
Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet (1995) 2.79
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int (2006) 2.64
Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet (2001) 2.35
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
Genetic variants in pre-eclampsia: a meta-analysis. Hum Reprod Update (2013) 2.28
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int (1999) 2.26
Expression of connective tissue growth factor in human renal fibrosis. Kidney Int (1998) 2.19
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol Dial Transplant (2011) 2.04
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int (2006) 1.92
The clinical spectrum of shunt nephritis. Nephrol Dial Transplant (1997) 1.78
Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol (2001) 1.77
Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun (1997) 1.76
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69
First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut (1998) 1.68
Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation (1999) 1.66
Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation (2001) 1.65
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group. Circulation (2000) 1.65
Case of lethal multiple pterygium syndrome with special reference to the origin of pterygia. Am J Med Genet (1989) 1.63
Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation (1998) 1.61
Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia (2010) 1.60
Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice. Diabetologia (2013) 1.59
The nephronophthisis complex. A clinicopathologic study in children. Virchows Arch A Pathol Anat Histol (1982) 1.59
Reversibility of capillary density after discontinuation of bevacizumab treatment. Ann Oncol (2009) 1.54
Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol (1998) 1.54
Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant (2009) 1.53
GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy. Kidney Int (2008) 1.52
Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrol Dial Transplant (1996) 1.52
Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease? Clin Nephrol (2006) 1.51
Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation. Neth J Med (2001) 1.50
Increased rectal cell proliferation following alcohol abuse. Gut (2001) 1.49
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation (1997) 1.48
Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation. Transplantation (2000) 1.48
The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol (1997) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol (1998) 1.47
Effect of danaparoid sodium on hard exudates in diabetic retinopathy. Lancet (1997) 1.46
Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood (1993) 1.46
Body growth in primary de Toni-Debré-Fanconi syndrome. Pediatr Nephrol (1997) 1.44
Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis (2003) 1.44
Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum (1992) 1.44
The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart (2014) 1.43
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation (1999) 1.43
Mutational analysis of the RPGRIP1L gene in patients with Joubert syndrome and nephronophthisis. Kidney Int (2007) 1.43
Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis. Hepatology (1989) 1.42
Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res (2002) 1.42
Prenatal diagnosis of acute non-lymphoblastic leukaemia in Down syndrome. Lancet (1990) 1.41
Endothelin-1-induced vasopressor responses in essential hypertension. Hypertension (1997) 1.41
Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree. Am J Hum Genet (2000) 1.41
Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat. Transplantation (2000) 1.40
Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy. J Rheumatol (1996) 1.40
[Schistosomiasis and signet ring cell carcinoma of the ileocecal valve]. Dtsch Med Wochenschr (1994) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther (1997) 1.37
High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol (1995) 1.35
The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol (1978) 1.35
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet (1995) 1.30
Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int (1995) 1.29
Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia (2002) 1.28
Diagnostic significance of anticytoplasmatic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of vasculitis. Nephron (1988) 1.27
5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation (1998) 1.27
Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res (2000) 1.26
Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest (1991) 1.25
Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int (1998) 1.25
The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant (1996) 1.25
Prenatal diagnosis of autosomal dominant polycystic kidney disease with a DNA probe. Lancet (1986) 1.25
Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 1.24
Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol (2002) 1.23
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol (1991) 1.23
The value of immunohistochemistry for collagen IV expression in colorectal carcinomas. Cancer (1991) 1.22
Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol (2006) 1.22
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. Clin Nephrol (1980) 1.22
Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis (2004) 1.22
Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford) (2003) 1.21
Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol (1996) 1.21
Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant (1997) 1.21
Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation (1998) 1.20
Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet (2000) 1.20
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20
Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett (1998) 1.20
Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis (2001) 1.19
Cellular localization and tissue distribution of polycystin-1. J Pathol (1999) 1.18
Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol (1994) 1.17
Percutaneous renal biopsy in children: a 27-year experience. Nephron (1998) 1.15
Adjuvanticity of lactobacilli. I. Differential effects of viable and killed bacteria. Clin Exp Immunol (1979) 1.15